| Original language | English |
|---|---|
| Pages (from-to) | 38-39 |
| Journal | Pharmacoepidemiology and Drug Safety |
| Volume | 30 |
| State | Published - Aug 2021 |
Changes in buprenorphine utilization during the COVID-19 pandemic in the US
Lindsey Hammerslag, Svetla Slavova, Jeffery Talbert, Sharon L. Walsh, Michelle Lofwall, Patricia R. Freeman
- Biostatistics
- Substance Use Priority Research Area
- Internal Medicine
- Institute for Biomedical Informatics
- Pharmacy Practice and Science
- Neuroscience Research Priority Area
- UNITE Research Priority Area
- Behavioral Science
- Center on Drug and Alcohol Research (CDAR)
- Pharmaceutical Sciences
- Pharmacology and Nutritional Sciences
- Psychiatry
- Family and Community Medicine
Research output: Contribution to journal › Meeting Abstract › peer-review